全文获取类型
收费全文 | 248011篇 |
免费 | 16877篇 |
国内免费 | 1388篇 |
专业分类
耳鼻咽喉 | 2653篇 |
儿科学 | 6245篇 |
妇产科学 | 4713篇 |
基础医学 | 30858篇 |
口腔科学 | 4662篇 |
临床医学 | 25482篇 |
内科学 | 51836篇 |
皮肤病学 | 3617篇 |
神经病学 | 24593篇 |
特种医学 | 10648篇 |
外国民族医学 | 24篇 |
外科学 | 38712篇 |
综合类 | 4001篇 |
现状与发展 | 2篇 |
一般理论 | 180篇 |
预防医学 | 17328篇 |
眼科学 | 5914篇 |
药学 | 16633篇 |
9篇 | |
中国医学 | 736篇 |
肿瘤学 | 17430篇 |
出版年
2023年 | 1496篇 |
2022年 | 2576篇 |
2021年 | 5912篇 |
2020年 | 3529篇 |
2019年 | 5535篇 |
2018年 | 6545篇 |
2017年 | 4910篇 |
2016年 | 5352篇 |
2015年 | 6367篇 |
2014年 | 9073篇 |
2013年 | 12041篇 |
2012年 | 18299篇 |
2011年 | 18957篇 |
2010年 | 10845篇 |
2009年 | 9921篇 |
2008年 | 16574篇 |
2007年 | 17410篇 |
2006年 | 16869篇 |
2005年 | 16629篇 |
2004年 | 15616篇 |
2003年 | 14243篇 |
2002年 | 13585篇 |
2001年 | 2222篇 |
2000年 | 1704篇 |
1999年 | 2225篇 |
1998年 | 2887篇 |
1997年 | 2307篇 |
1996年 | 2006篇 |
1995年 | 1828篇 |
1994年 | 1591篇 |
1993年 | 1554篇 |
1992年 | 1070篇 |
1991年 | 995篇 |
1990年 | 864篇 |
1989年 | 800篇 |
1988年 | 728篇 |
1987年 | 656篇 |
1986年 | 682篇 |
1985年 | 728篇 |
1984年 | 942篇 |
1983年 | 806篇 |
1982年 | 1057篇 |
1981年 | 984篇 |
1980年 | 847篇 |
1979年 | 484篇 |
1978年 | 532篇 |
1977年 | 462篇 |
1976年 | 430篇 |
1975年 | 331篇 |
1974年 | 338篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kamolz Lars-Peter Kotzbeck Petra Schintler Michael Spendel Stephan 《European Surgery》2022,54(3):163-169
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of... 相似文献
2.
3.
4.
5.
Kow Chia Siang Ramachandram Dinesh Sangarran Hasan Syed Shahzad 《Journal of thrombosis and thrombolysis》2022,54(2):217-218
Journal of Thrombosis and Thrombolysis - 相似文献
6.
7.
8.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
9.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献